2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

Journal of the American College of Cardiology, Journal Year: 2022, Volume and Issue: 79(17), P. e263 - e421

Published: April 1, 2022

Language: Английский

---

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation

Journal of the American College of Cardiology, Journal Year: 2023, Volume and Issue: 83(1), P. 109 - 279

Published: Nov. 30, 2023

Language: Английский

---

2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction

Journal of the American College of Cardiology, Journal Year: 2023, Volume and Issue: 81(18), P. 1835 - 1878

Published: April 19, 2023

Language: Английский

---

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease

Journal of the American College of Cardiology, Journal Year: 2023, Volume and Issue: 82(9), P. 833 - 955

Published: July 20, 2023

Language: Английский

---

Coronary In-Stent Restenosis

Journal of the American College of Cardiology, Journal Year: 2022, Volume and Issue: 80(4), P. 348 - 372

Published: July 1, 2022

The introduction and subsequent iterations of drug-eluting stent technologies have substantially improved the efficacy safety percutaneous coronary interventions. However, incidence in-stent restenosis (ISR) resultant need for repeated revascularization still occur at a rate 1%-2% per year. Given that millions stents are implanted each year around globe, ISR can be considered as pathologic entity public health significance. mechanisms multifactorial. Since first description angiographic patterns ISR, advent intracoronary imaging has further elucidated ISR. armamentarium treatment strategies also evolved over time. Currently, an individualized approach using to characterize underlying substrate is recommended. In this paper, we comprehensively reviewed incidence, mechanisms, characterization propose contemporary algorithm.

Language: Английский

---

Investigation of the Associations of Novel Inflammatory Biomarkers—Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)—With the Severity of Coronary Artery Disease and Acute Coronary Syndrome Occurrence

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(17), P. 9553 - 9553

Published: Aug. 23, 2022

Atherosclerosis, the underlying cause of coronary artery disease (CAD), has a significant inflammatory component. White blood cell count is an affordable and accessible way to assess systemic immune response, as it comprises many subgroups with distinct complex functions. Considering their multidirectional effect on atherosclerosis, new biomarkers integrating various leukocyte subgroups, Systemic Inflammatory Index (SII) Response (SIRI), were recently devised describe balance between inflammation reaction. This research aimed evaluate relationship intensity measured by these severity CAD assessed angiography diagnosis acute syndrome (ACS) or stable in 699 patients. SIRI, but not SII, was associated diagnosis, having highest values for patients ACS (STEMI), significantly higher than (p < 0.01). The SII SIRI observed three-vessel CAD. require further in-depth well-designed potential clinical setting.

Language: Английский

---

Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association

Circulation, Journal Year: 2022, Volume and Issue: 147(3)

Published: Dec. 12, 2022

Diagnostic and therapeutic advances during the past decades have substantially improved health outcomes for patients with acute coronary syndrome. Both age-related physiological changes accumulated cardiovascular risk factors increase susceptibility to syndrome over a lifetime. Compared younger patients, in large growing demographic of older adults are relatively worse. Increased atherosclerotic plaque burden complexity anatomic disease, compounded by noncardiovascular comorbid conditions, contribute worse prognosis observed individuals. Geriatric syndromes, including frailty, multimorbidity, impaired cognitive physical function, polypharmacy, other complexities care, can undermine efficacy guidelines-based treatments resiliency survive recover, as well. In this American Heart Association scientific statement, we (1) review that predispose management complexity; (2) describe influence commonly encountered geriatric syndromes on disease outcomes; (3) recommend age-appropriate guideline-concordant revascularization strategies, transitions use cardiac rehabilitation, palliative care services, holistic approaches. The primacy individualized assessment patient-centered decision-making is highlighted throughout.

Language: Английский

---

Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials

The Lancet, Journal Year: 2023, Volume and Issue: 402(10410), P. 1338 - 1346

Published: Aug. 26, 2023

Language: Английский

---

Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis

The Lancet, Journal Year: 2024, Volume and Issue: 403(10429), P. 824 - 837

Published: Feb. 21, 2024

Language: Английский

---

Intravascular Imaging During Percutaneous Coronary Intervention

Journal of the American College of Cardiology, Journal Year: 2023, Volume and Issue: 81(6), P. 590 - 605

Published: Feb. 1, 2023

Language: Английский

---